CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FierceBiotech
Original article

{"a":[{"_":"Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs","$":{"href":"/biotech/deerfield-backed-boulevard-bio-strolls-65m-launch-and-trio-immunology-candidates","hreflang":"en"}}]}

Positive
AI Analysis

Summary

Boulevard Bio launched from stealth with $65 million in Series A funding from Deerfield Management and three autoimmune disease candidates in development.

Importance:5/10
Sentiment:
0.60
immunologyautoimmune diseaseSeries A fundingstealth launch
Related Companies

Read the original article

Published by FierceBiotech on August 11, 2026 1:12 PM

Read Original